November 6, 2015
FDA approves Genvoya
FDA has approved Genvoya, a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
November 5, 2015
Johnson&Johnson confimrs acquiring Novira Therapeutics
Johnson & Johnson has announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.
November 3, 2015
GlaxoSmithKline: Two drug injectable regimen for HIV therapy study shows positive result
ViiV Healthcare, a global specialist HIV company with GSK (GlaxoSmithKline), Pfizer Inc. and Shionogi Limited as shareholders, announced on Tuesday that the Phase IIb study LATTE 2 (NCT02120352) met its primary endpoint at 32 weeks.
November 3, 2015
Tufts CSDD says drug companies are in competitive development races to be first to market
Nearly all later entrants to drug classes had begun clinical testing or were in regulatory review in the United States before the first drug within a pharmacologic class was approved, a newly completed analysis from the Tufts Center for the Study of Drug Development suggests.
November 3, 2015
Janssen Applys to EMA to Expand Use of Imbruvica
Janssen-Cilag International NV announced on Tuesday the submission of a Type II variation application to the European Medicines Agency (EMA) seeking…
November 2, 2015
Lilly expands its Indianapolis R&D headquartes
Eli Lilly and Company has revealed plans to expand its global research and development (R&D) headquarters in Indianapolis, Indiana.
October 30, 2015
NIH researchers link single gene variation to obesity
A single variation in the gene for brain-derived neurotropic factor (BDNF) may influence obesity in children and adults, according to a new study funded by the National Institutes of Health.
October 30, 2015
Lonsurf for colerectal cancer patients approved by FDA
United States Food and Drug Administration (FDA) has approved Lonsurf (trifluridine and tipiracil) tablets for the treatment of patients with metastatic colorectal cancer who have been previously…
October 30, 2015
Allergan, Pfizer in merger talks
Allergan plc has confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction.
October 27, 2015
Health care costs for dementia found greater than for any other disease
In the last five years of life, total health care spending for people with dementia was more than a quarter-million…